Physician profile
Timothy Jay
NPI 1295121234
$8,919.93
in general payments reported to CMS, 2019-2025
14 companies · $2,906 in 2025
The $2,906 reported for 2025 was more than what 76% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,356 · 2021: $1,521 · 2022: $1,321 · 2023: $219 · 2024: $1,597 · 2025: $2,906.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,907 · Food and Beverage: $1,815.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,906.64 |
| Food and Beverage | $1,815.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gemini Medical LLC | $2,154.26 | 2020-2022 | |
| Depuy Synthes Sales INC. | $1,653.54 | 2020-2025 | Inhance, Attune |
| Foundation Medical, LLC | $1,439.31 | 2022-2025 | |
| Pacira Pharmaceuticals Incorporated | $1,225.38 | 2025 | Iovera |
| Arthrex, INC. | $1,170.98 | 2021-2025 | |
| Exactech, INC. | $858.59 | 2025 | |
| Medical Device Business Services, INC. | $146.69 | 2023-2024 | Inhance, Velys |
| Stryker Corporation | $110.47 | 2022-2024 | Triathlon |
| Vericel Corporation | $39.05 | 2022-2025 | Maci |
| Medtronic, INC. | $33.34 | 2024 | Aquamantys(Tm) |
| Orthalign INC | $30.53 | 2021 | |
| Kerecis Limited | $24.89 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Sanofi-Aventis U.S. LLC | $17.69 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.21 | 2025 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Jay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.